These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 954684)

  • 1. Immunological studies on LATS-immunogloblin by the reaction with staphylococcal protein A.
    Ochi Y; Yoshimura M; Hachiya T; Miyazaki T
    Endocrinol Jpn; 1976 Apr; 23(2):183-6. PubMed ID: 954684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of LATS activity in immunoglobulin G subclass.
    Ochi Y; Yoshimura M; Hachiya T; Miyazaki T
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):791-8. PubMed ID: 578059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the purification and the immunological properties of LATS-immunoglobulin (author's transl].
    Miyazaki T
    Nihon Naibunpi Gakkai Zasshi; 1978 Jul; 54(7):815-28. PubMed ID: 710642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for separation of long-acting thyroid stimulator (LATS) from sera containing LATS and TSH.
    Ochi Y; Hachiya T; Yoshimura M; Miyazaki T
    Metabolism; 1977 Jul; 26(7):773-9. PubMed ID: 865284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that both long-acting thyroid stimulator and long-acting thyroid stimulator-protector stimulate the human thyroid gland.
    Holmes SD; Dirmikis SM; Martin TJ; Munro DS
    J Endocrinol; 1979 Feb; 80(2):215-21. PubMed ID: 220366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin binding and long acting thyroid stimulator absorbing activities in subcellular fractions from isolated thyroid cells and thyroid homogenates.
    Mehdi SQ; Badger J; Kriss JP
    Endocrinology; 1977 Jul; 101(1):59-65. PubMed ID: 193685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum long acting thyroid stimulator (LATS) and LATS-protector (LATS-P) in Graves' disease associated with localized myxedema.
    Hardisty CA; Fowles A; Munro DS
    J Endocrinol Invest; 1984 Apr; 7(2):151-5. PubMed ID: 6547156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of LATS in a patient with Graves' disease complicated by nephrotic syndrome.
    Kajita Y; Miyoshi Y; Hachiya T; Miyazaki T; Yoshimura M; Ijiichi H; Ochi Y
    Endocrinol Jpn; 1980 Dec; 27(6):727-32. PubMed ID: 6790269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On incubation of long acting thyroid stimulator with human thyroid and adrenal homogenates.
    Dandona P; El Kabir DJ
    Clin Endocrinol (Oxf); 1980 Apr; 12(4):379-83. PubMed ID: 6247108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of in vivo triiodothyronine and long acting thyroid stimulator (LATS) administration on the vitro thyroid cAMP response to thyrotrophin and LATS.
    Ikeda H; Chiu SC; Kuzuya N; Uchimura H; Nagataki S
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):193-8. PubMed ID: 6328822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
    Knight A; Adams DD
    Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of iodinization on some properties of LATS and antithyroid antibodies].
    Romaldini JH; Pinchera A; Fenzi GF; Grasso L; Raccis E; Mariotti S; Baschieri L
    Folia Endocrinol; 1974 Feb; 27(1):110-6. PubMed ID: 4549507
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-acting thyroid stimulator (LATS) and long acting thyroid stimulator protector (LATS-P) in untreated thyrotoxicosis.
    Hardisty CA; Hanford L; Humphries H; Munro DS
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):631-9. PubMed ID: 6895353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of thyroid adenyl cyclase by antisera to thyroid plasma membrane preparations: effects of IgG and non-IgG antiserum components.
    Ong M; Malkin DG; Malkin A
    Metabolism; 1986 Apr; 35(4):292-6. PubMed ID: 3754301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical studies to purify rabbit and chicken immunoglobulin G antibody by protein A-Sepharose chromatography.
    Ansari AA; Chang TS
    Am J Vet Res; 1983 May; 44(5):901-6. PubMed ID: 6408954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LATS-protector activity in thyrotoxicosis measured by thyroidal intracellular colloid droplet formation.
    Shishiba Y; Miyachi Y; Takaishi M; Ozawa Y
    J Clin Endocrinol Metab; 1978 May; 46(5):841-8. PubMed ID: 262769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone secretion is more sensitive than thyroid cyclic AMP accumulation to stimulation with LATS in mice in vitro and in vivo.
    Ikeda H; Chiu SC; Kuzuya N; Uchimura H; Nagataki S
    J Endocrinol Invest; 1984 Feb; 7(1):1-6. PubMed ID: 6325527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of thyroactive smaller components released from TSAb-IgG by protease digestion.
    Ogura M; Kouki T; Inui T; Hachiya T; Ochi Y; Kajita Y
    Thyroid; 1995 Dec; 5(6):449-54. PubMed ID: 8808094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
    Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and properties of a novel IgG-binding protein from streptococci of serological group U.
    Chhatwal GS; Blobel H
    Med Microbiol Immunol; 1987; 176(1):1-12. PubMed ID: 3821654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.